CAVAC

We specialize in animal vaccines. We specialize in animal vaccines. We specialize in animal vaccines.
CAVAC has grown into a leading animal vaccine company in Korea
with the trust of our customers, carrying out the entire process from development to supply.
VISION
Global Bio Leader,
pursuing a dream for animal health and human welfare
CORE VALUES
신뢰
Trust
  • Recognizing and rewarding efforts and achievements
  • Being responsible and devoted
  • Respecting different opinions
고객가치
Customer value
  • Predicting and responding to the customers needs
  • Satisfying the customers with the highest level of quality
  • Offering timely and professional services
전문성
Professionalism
  • Providing expert and professional service
  • Sharing knowledge and experiences
  • Using up-to-date information and technology
Beyond Korea, To the World
CAVAC is the top exporter of animal vaccines in Korea,
supplying products to over 20 countries worldwide.
지도 지도 지도 지도 지도 지도
CAVAC's Unwavering Commitment
  • Since our founding in 1968, CAVAC has dedicated all of our expertise and resources to advancing animal vaccine development. We are driven by our commitment to protecting animal health and welfare. Through strategic partnerships with leading research institutions worldwide, proprietary technologies, and sustained investment in specialized talent and state-of-the-art production facilities, we have built a strong foundation for innovation and quality excellence.
Korea's Leading Animal Vaccine Company
  • These efforts have positioned CAVAC as Korea's No.1 animal vaccine manufacturer, commanding the largest market share in domestic exports. We supply approximately 80 vaccines to the Korean market. As we maintain this leadership position, we continue to drive innovation and develop solutions for the industry's most pressing challenges in both livestock and companion animal health.
Sustained Global Expansion
  • In the highly competitive global animal health market, CAVAC has achieved consistent growth by delivering world-class quality. Our quality standards have been validated through GMP inspections by multinational pharmaceutical companies and leading regulatory authorities. Since launching our export operations in 1993, we have steadily expanded our international presence. We have earned significant recognition including the "10 Million Dollar Export Tower," designation as a "Promising Export Company," and the IHS Markit "Animal Health Award 2020" for Best Company in the Asia-Oceania region. We remain committed to penetrating new markets through active participation in international conferences and overseas R&D partnerships.